ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

31198 results sorted by trial registration date.
  • Selection of Patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for Rehabilitation: A pilot study

    This study seeks to improve mid to long term outcomes and reduce frailty in post-TAVR patients by implementing a 3-month CR program in an outpatient setting which will include individualised exercise and education. The proposed study aims to provide a model of care that can be implemented in future community settings. Study hypothesis: 1) Patients who engage in outpatient exercise training program will have reduced frailty at six-months post-TAVR, and 2) patients who benefit most can be predicted.

  • AUstralasian thoRacic cancers lOngitudinal cohoRt study and biobAnk (AURORA)

    AURORA is an Australasian multisite observational cohort study and biobank study that is seeking to create a representative data set on the current cancer features, diagnostics, treatments and outcomes for people diagnosed with thoracic cancers. Who is it for? You may be eligible for this study if you are an adult who has suspected or positively been diagnosed with a thoracic cancer, including non-small cell lung cancer, small cell lung cancer, mesothelioma, thymoma, thymic carcinoma, and/or carcinoid tumours. If you are eligible for this study, you may be enrolled at diagnosis, upon referral to a participating centre, or at any stage of your cancer treatment journey. Study details Participants who choose to enrol in this study may be asked if they would like to provide blood and tissue samples, complete questionnaires about their symptoms, and permit access to health service data (from Medicare or the medicines/pharmacy database). These activities usually do not require additional study visits; instead, they will take place during regular appointments. Data about cancer and treatments will be collected as part of routine care follow-up, approximately every 3 to 6 months for as long as care is ongoing. As this is an observational study, participants will not be offered any non-standard of care treatments for their cancer. Participants who have previously been involved in cancer studies (Thoracic Malignancies Study [Peter Mac, 2012–2018] or Australian Registry and Biobank of Thoracic Cancers [Australian sites, 2018–2024]) will have their data and follow-up transitioned to this study, which replaces the previous study protocols. The ethics committee has determined that no further action is required from participants for this transition to take place. It is hoped that this study will allow clinicians and researchers to better understand thoracic cancers, how these are being treated and how patients are responding to their chosen cancer treatments in Australian clinical practice. It is hoped this information can then be used to identify the best diagnosis methods and the most effective treatments for the different types of thoracic cancer, which can then be used to provide better outcomes for future patients with thoracic cancer.

  • The effect of a topical curcumin formulation (VAS101) on knee pain in adults with knee osteoarthritis

    In this randomised, double-blind, placebo-controlled study, 60 adults aged 40 to 75 years with knee osteoarthritis will be randomly assigned to receive either topical administrations of a gel containing curcumin (VAS101) or a placebo. These gels will be applied every 2 days for 28 days. Changes in knee pain and osteoarthritis symptoms will be examined using validated self-report measures, several performance-based tasks, and a urinary marker associated with disease progression in osteoarthritis. Changes in the use of rescue medications for knee pain will also be examined over time. It is hypothesised that compared to the placebo gel, the application of VAS101 will be associated with a greater reduction in knee pain and other knee-related osteoarthritis symptoms; and larger improvements in several performance-based tasks.

  • The Alcohol Cue Exposure and Virtual Reality Project

    Many Australians do not realise that they engage in harmful drinking behaviours and meet diagnostic criteria for alcohol use disorder (AUD). If they are aware, many do not feel motivated to reduce or cease their drinking. While brief motivational interventions have been shown to increase motivation to reduce drinking and therefore, improve treatment outcomes in individuals with AUD, effect sizes are modest at best. Neuropsychological feedback (NPF) is an evidence-based intervention that can be delivered as a brief intervention, and has been found to improve clinical outcomes in other neuropsychological and mental health conditions. Yet, its efficacy and acceptability for AUD remain unclear. In this RCT, we aimed to investigate the efficacy and acceptability of NPF for AUD, compared with an active control, a brief motivational intervention. We hypothesised that adults with AUD who receive NPF would show greater reduction in alcohol use and greater improvement in clinical outcomes (i.e., alcohol craving, psychological distress, and alcohol-related self-efficacy) than those who receive a traditional brief motivational intervention.

  • Strength in Numbers: A classroom based resistance training and mathematics intervention

    Classroom activity breaks have gained traction as an effective strategy for increasing student on task behaviour and academic achievement. Despite these promising results, there remains a gap in the research regarding the effectiveness of activity breaks in secondary school environments. Strength in Numbers is an innovative educational pedagogy that integrates muscle strengthening activities into mathematics lessons. The intervention consists of a series of 5-minute videos that presents numeracy questions aligned with the NSW mathematics syllabus. Students indicate their answer by performing a corresponding muscle-strengthening activity. These activities are designed to be simple, quick, and effective and require no additional equipment or space. It is hypothesised that by combining movement and syllabus outcomes students will find learning less stressful and may improve on task behaviour for up to 30 minutes following the intervention.

  • Screening for Aortic Stenosis Using Gyrocardiography (GCG)

    This study aims to evaluate gyrocardiography (GCG) as a diagnostic screening tool that detects the presence of aortic stenosis. GCG data will be obtained from 300 participants with either normal aortic valves or mild, moderate or severe aortic stenosis. The results of the GCG data will be compared to that obtained by echocardiography, the gold standard. We hypothesise that GCG will accurately identify aortic stenosis with high sensitivity and specificity - it will be able to detect patients who truly have the disease, and exclude those that do not. This will benefit patients by improving doctors’ ability to diagnose aortic stenosis and more quickly refer onwards for treatment that may be needed.

  • A Study to Investigate the Management of Patients using LImited-channel testing versus Full polysomnography for Identification of Obstructive Sleep Apnoea (SIMPLIFI-OSA)

    This study will compare the effects of simplified sleep study testing (with fewer monitoring channels than usual) versus full sleep studies for the diagnosis of obstructive sleep apnea (OSA), by investigating the accuracy of 3 different simplified sleep study devices, their impacts on physician decision-making and important patient outcomes (including symptoms of daytime sleepiness) and whether the use of simplified testing devices in the management of OSA is associated with significant cost savings. The study hypothesis is that limited-channel sleep study testing is accurate, effective and cost-effective compared to full sleep study testing in the diagnosis and management of patients with suspected OSA.

  • Subcutaneous injections of benzathine penicillin G (SCIP) for rheumatic heart disease in Kununurra

    People living with rheumatic fever and rheumatic heart disease are often recommended to have antibiotic injections at least every 28-days over five years to reduce their risk of permanent heart damage. Our team has developed a new, less painful, way to deliver the antibiotic, called ‘SCIP’, which provides 10-weeks of protection. By partnering with the Ord Valley Aboriginal Health Service, we will offer SCIP to people in need of regular BPG in Kununurra, Western Australia, and evaluate how well it works for them, with the ultimate goal of using SCIP to reduce rheumatic heart disease morbidity. We hypothesize that SCIP will provide an acceptable alternative way for people to get their regular BPG.

  • Underlying Mechanisms of Non-Invasive Brain Stimulation on the Cognitive and Mood Symptoms of Menopause: A Randomised, Sham-Controlled, Double-Blinded, Pilot Clinical Trial (MenoStim Trial)

    The aim of this research is to investigate how a potential treatment works for the cognitive and mood symptoms experienced during menopause through a form of non-invasive brain stimulation. Transcranial magnetic stimulation (TMS) is a technique that can alter activation in certain areas of the brain by using magnetic stimulation. This stimulation is non-invasive, which means it is applied to the top of your scalp. The stimulation then travels through the scalp and into the brain. Specific forms of TMS, like intermittent theta-burst stimulation (iTBS) are promising treatments for depression, memory, and thinking. We hypothesise that this may be a promising treatment option that can improve cognition and mood in females going through the late menopause transition. This research will address this evidence-practice gap by testing whether the treatment works.

  • Evaluation of the performance of a non-contact and non-invasive Hyperparallel optical coherence tomography device in measuring retinal layers of normal eyes and eyes with diseases.

    The proposed study will be a prospective, observational, non-intervention study that will collect clinical ocular measurements from a range of participants including those with healthy and diseased retinas to allow comparison of the Cylite Hyperparallel Optical Coherence Tomographer (HP-OCT) with the Heidelberg Spectralis Spectral-Domain Optical Coherence Tomographer (SD-OCT). The main objective of this study is to evaluate the validity and repeatability of the retinal layer segmentation of images acquired with the HP-OCT.

Tags:
  • Finding clinical trials